DANBURY, Conn.--(BUSINESS WIRE)--IMS Health Holdings, Inc. (“IMS Health”) (NYSE:IMS) will issue its second-quarter 2015 financial results before the market opens on Friday, July 31, 2015. The press release and accompanying financial information will be posted on the IMS Health Investor Relations website at http://ir.imshealth.com.
IMS Health’s management team will host a conference call and webcast to discuss the company’s results at 9:00 a.m. Eastern Time on July 31. Interested parties are invited to listen to the live event and view the presentation slides via webcast on IMS Health’s Investor Relations website at http://ir.imshealth.com. The discussion also will be available by dialing +1-800-728-2056 in the U.S. and Canada, or +1-212-231-2901 for international callers.
A replay of the webcast will be available approximately two hours after the conclusion of the live event on July 31. To access the webcast recording, visit http://ir.imshealth.com.
About IMS Health
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance. End-to-end proprietary applications and configurable solutions connect 10+ petabytes of complex healthcare data through the IMS OneTM cloud platform, providing comprehensive insights into diseases, treatments, costs and outcomes. The company’s 15,000 employees blend global consistency and local market knowledge across 100 countries to help clients run their operations more efficiently. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
As a global leader in protecting individual patient privacy, IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes.